Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 4/20 | 0.46 |
| ▸ | CA2 | P00918 | 4/20 | 0.46 |
| ▸ | CA7 | P43166 | 3/20 | 0.46 |
| ▸ | CA9 | Q16790 | 3/20 | 0.46 |
| ▸ | CA12 | O43570 | 1/20 | 0.46 |
| ▸ | CA4 | P22748 | 1/20 | 0.46 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.43 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.43 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.43 |
| ▸ | APP | P05067 | 1/20 | 0.42 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.42 |
| ▸ | TOP1 | P11387 | 1/20 | 0.39 |
| ▸ | TP53 | P04637 | 2/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | DCUN1D1 | Q96GG9 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 3/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL217122 | 0.81 | ALDH1A1 (0.32) | ALDH1A1PTGS2DCUN1D1HPGDSMN1; SMN2 | |
| SCHEMBL4921197 | 0.79 | ALDH1A1 (0.48) | ALDH1A1TDP1MAPTKDM4EHPGD | |
| SCHEMBL218366 | 0.79 | RAB9A (0.47) | CA1CA2CA7CA9CA12 | |
| SCHEMBL328869 | 0.77 | NCOA1 (0.40) | ALDH1A1PTGS2TSHRKMT2AHPGD | |
| SCHEMBL4916059 | 0.77 | CYP1A2 (0.42) | ALDH1A1TP53TSHRMAPTKDM4E | |
| SCHEMBL7525316 | 0.76 | CA1 (0.47) | CA1CA2CA7CA9CA12 | |
| SCHEMBL4915520 | 0.75 | CYP1A2 (0.53) | MAPTKDM4EMEN1KMT2ALMNA | |
| SCHEMBL4723230 | 0.75 | ALDH1A1 (0.43) | ALDH1A1TDP1PTGS2TP53MAPT | |
| SCHEMBL4721475 | 0.74 | MAPT (0.50) | ALDH1A1TDP1MAPTKDM4EMEN1 | |
| SCHEMBL6891983 | 0.74 | GPR84 (0.45) | ALDH1A1APPPTGS2HTR7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 111 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9296738-B2 | Organic electroluminescent material, the process for preparing the same and OLED device using the same | EVERDISPLAY OPTRONICS (SHANGHAI) LIMITED (CN) | 2016-03-29 | — | — | US | claimed |
| US-20150203485-A1 | ORGANIC ELECTROLUMINESCENT MATERIAL, THE PROCESS FOR PREPARING THE SAME AND OLED DEVICE USING THE SAME | EVERDISPLAY OPTRONICS (SHANGHAI) CO., LTD. (CN) | 2015-07-23 | — | — | US | claimed |
| EP-3438102-B1 | GLYCIDYL ESTER COMPOUND PREPARATION METHOD | KOLON INC (KR) | 2021-07-07 | — | — | EP | disclosed |
| US-10954206-B2 | Glycidyl ester compound preparation method | KOLON INDUSTRIES, INC. (KR) | 2021-03-23 | — | — | US | disclosed |
| US-20200299247-A1 | GLYCIDYL ESTER COMPOUND PREPARATION METHOD | KOLON INDUSTRIES, INC. (KR) | 2020-09-24 | — | — | US | disclosed |
| EP-3495424-B1 | COMPOSITION FOR PHOTO-ALIGNMENT LAYER AND PHOTO-ALIGNMENT LAYER | LG CHEMICAL LTD (KR) | 2020-09-09 | — | — | EP | disclosed |
| CN-107109231-B | Vertically oriented layer comprising cyclic olefin (co) polymer | 株式会社LG化学 | 2020-03-06 | — | — | CN | disclosed |
| US-10453420-B2 | Base film, laminated structure including the same, and display device | LG CHEM, LTD. (KR) | 2019-10-22 | — | — | US | disclosed |
| EP-3495424-A1 | COMPOSITION FOR PHOTO-ALIGNMENT LAYER AND PHOTO-ALIGNMENT LAYER | LG Chem, Ltd. (KR) | 2019-06-12 | — | — | EP | disclosed |
| EP-3196236-B1 | VERTICAL ALIGNMENT FILM COMPRISING (CO)POLYMER OF CYCLIC OLEFIN COMPOUND | LG CHEMICAL LTD (KR) | 2019-04-10 | — | — | EP | disclosed |
| US-20190079060-A1 | Pretreatment Method For Analyzing Dioxin Compounds And Analytical Method Using The Same | LG CHEM, LTD. (KR) | 2019-03-14 | — | — | US | disclosed |
| US-20080200475-A1 | 4-Piperazinothieno[2,3-D] Pyrimidine Compounds As Platelet Aggregation Inhibitors | PFIZER INC. | 2008-08-21 | — | — | US | disclosed |
| US-20070293640-A1 | Multiple catalyst system for olefin polymerization and polymers produced therefrom | EXXONMOBIL CHEMICAL PATENTS INC. | 2007-12-20 | — | — | US | disclosed |
| EP-1866317-A1 | 4-PIPERAZINOTHIENO [2, 3-D] PYRIMIDINE COMPOUNDS AS PLATELET AGGREGATION INHIBITORS | Pharmacia & Upjohn Company LLC (US) | 2007-12-19 | — | — | EP | disclosed |
| US-7294681-B2 | Mutliple catalyst system for olefin polymerization and polymers produced therefrom | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2007-11-13 | — | — | US | disclosed |
| US-7223822-B2 | Multiple catalyst and reactor system for olefin polymerization and polymers produced therefrom | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2007-05-29 | — | — | US | disclosed |
| WO-2006103555-A1 | 4-PIPERAZINOTHIENO [2, 3-D] PYRIMIDINE COMPOUNDS AS PLATELET AGGREGATION INHIBITORS | PHARMACIA & UPJOHN COMPANY LLC (US) | 2006-10-05 | — | — | WO | disclosed |
| EP-1473323-A1 | Polyethylene composition and process for producing same | Tosoh Corporation (JP) | 2004-11-03 | — | — | EP | disclosed |
| US-20040214953-A1 | Polyethylene composition and process for producing same | TOSOH CORPORATION | 2004-10-28 | — | — | US | disclosed |
| US-5688735-A | COORDINATION CATALYST | FINA TECHNOLOGY, INC. (US) | 1997-11-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150203485-A1 | ORGANIC ELECTROLUMINESCENT MATERIAL, THE PROCESS FOR PREPARING THE SAME AND OLED DEVICE USING THE SAME | OCIAD1, OCIAD2, OR10J3 | CA1 3607/4885CA2 3257/4885CA7 4138/4885 |
| US-20200299247-A1 | GLYCIDYL ESTER COMPOUND PREPARATION METHOD | AGER, CYP4A11, GK | CA1 3545/4885CA2 3144/4885CA7 641/4885 |
| US-10954206-B2 | Glycidyl ester compound preparation method | AGER, CYP4A11, GK | CA1 3545/4885CA2 3144/4885CA7 641/4885 |
| US-20080200475-A1 | 4-Piperazinothieno[2,3-D] Pyrimidine Compounds As Platelet Aggregation Inhibitors | PF4, TBXA2R, P2RY4 | CA1 4557/4885CA2 2288/4885CA7 4121/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.